Navigation Links
New skin gel fights breast cancer without blood clot risk
Date:7/15/2014

CHICAGO --- A gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer reduced the growth of cancer cells to the same degree as the drug taken in oral form but with fewer side effects that deter some women from taking it, according to new Northwestern Medicine research.

Tamoxifen is an oral drug that is used for breast cancer prevention and as therapy for non-invasive breast cancer and invasive cancer.

Because the drug was absorbed through the skin directly into breast tissue, blood levels of the drug were much lower, thus, potentially minimizing dangerous side effects -- blood clots and uterine cancer.

The gel was tested on women diagnosed with the non-invasive cancer ductal carcinoma in situ (DCIS) in which abnormal cells multiply and form a growth in a milk duct. Because of potential side effects, many women with DCIS are reluctant to take oral tamoxifen after being treated with breast-saving surgery and radiation even though the drug effectively prevents DCIS recurrence and reduces risk of future new breast cancer.

The paper was published July 15 in the journal Clinical Cancer Research.

"Delivering the drug though a gel, if proven effective in larger trials, could potentially replace oral tamoxifen for breast cancer prevention and DCIS and encourage many more women to take it," said lead author Seema Khan, M.D., a Northwestern Medicine surgical oncologist. "For breast cancer prevention and DCIS therapy, effective drug concentrations are required in the breast. For these women, high circulating drug levels only cause collateral damage."

Khan is a professor of surgery and the Bluhm Family Professor of Cancer Research at Northwestern University Feinberg School of Medicine. She also is a surgeon at Northwestern Memorial Hospital and co-leader of the breast cancer program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University

"The gel minimized exposure to the rest of the body and concentrated the drug in the breast where it is needed," Khan said. "There was very little drug in the bloodstream which should avoid potential blood clots as well as an elevated risk for uterine cancer."

Women who have completed surgery and radiation are given oral tamoxifen for five years to reduce the risk of the DCIS recurring at the same place and of new breast cancer appearing elsewhere in the same breast or the other breast. Tamoxifen is an anti-estrogen therapy for a type of breast cancer that requires estrogen to grow.

Khan and colleagues conducted a phase II clinical trial to compare the effects of the gel, 4-OHT, with oral tamoxifen. They found after six to 10 weeks of gel application that the reduction in a marker for cancer cell growth, Ki-67, in breast tissue was similar to that of oral tamoxifen. The scientists also found equal amounts of 4-OHT present in the breast tissue of patients who used the gel or took the oral drug, but the blood levels of 4-OHT were more than five times lower in those who used the gel.

The reduction in the levels of 4-OHT in the blood also was correlated with a reduction in proteins that cause blood clots.

The study involved 26 women, ages 45 to 86, who had been diagnosed with DCIS that was sensitive to estrogen (estrogen-receptor-positive DCIS). Half the women received the gel, which they applied daily, and half the oral drug, which they took daily.

The gel application may also be more effective for some women. Oral tamoxifen doesn't help all women who take it because it needs to be activated in the liver by specific enzymes and about a third of women lack these enzymes, Khan said. These women may not receive full benefits from the pill.


'/>"/>

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Related medicine news :

1. Fitness Fights High Blood Pressure, Even With Family History
2. Not Fair! How Sibling Fights May Lead to Later Mood Problems
3. Local Plastic Surgeon Fights Cancer via Facebook
4. Electrical Brain Stimulation Plus Drug Fights Depression: Study
5. Scientists Explore How Zinc Fights Off Infection
6. Research Foundation for Tick-Borne Infections Fights Lyme Disease, Babesiosis and Encephalitis with Pilot Studies
7. Sons of Absent or Abusive Fathers May Pick More Bar Fights: Survey
8. Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’
9. Sport-Social for Autism Fights to Win Contest
10. All Natural Sunscreen Fights Hunger
11. New Book Shows Children How the Body Fights Germs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2019)... ... August 23, 2019 , ... ... with the West Virginia Eye Collaborative. This partnership will be managed by Coherent ... of care, the WV Eye Collaborative and its eye physicians will be strategically ...
(Date:8/21/2019)... HUNTSVILLE, Ala. (PRWEB) , ... August 21, 2019 ... ... recovery program, will open a new location in Huntsville, Ala. in early 2020. ... Partial Hospitalization Program (PHP) and an Intensive Outpatient Program (IOP). The integrative program ...
(Date:8/21/2019)... ... 21, 2019 , ... Future residents got their first look ... expansion of Providence Point in Pittsburgh’s Scott Township neighborhood involved additions, changes, and ... apartment tower, Hamilton Tower. , The expansion began two years ago ...
(Date:8/19/2019)... ... August 19, 2019 , ... Professional Enrollment Concepts (PEC), a ... announces they have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies ... at the most successful companies within the American economy's most dynamic segment—its independent ...
(Date:8/17/2019)... (PRWEB) , ... August 17, 2019 , ... ... List of America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year ... With Three-Year Revenue Growth of 192% Percent , Inc. magazine today revealed that ...
Breaking Medicine News(10 mins):
(Date:8/19/2019)... ... August 19, 2019 , ... The International Association of Eating ... within the field of treatment for eating disorders, recommends membership for professionals who ... have a similar mission. , Founded in 1985, the iaedp™ Foundation is ...
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center ... of Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The ... Houston Heights, is aimed at helping Houston families get their children caught up ...
(Date:8/16/2019)... ... August 16, 2019 , ... Today, Point-of-Care Partners announced Government ... has joined the company as a Government Affairs and Health IT Strategist. In ... standards organizations to advance use of health IT for comprehensive medication management. , ...
Breaking Medicine Technology: